ARCHIVES

Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

Final Issue of the Year

December 13, 1985

NCI Cooperative Group, Cancer Center Trials Listed

February 29, 2008

New Drug Reduces Nausea and Vomiting

October 31, 2003

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

December 27, 2002

Cancer Control, Smoking Programs Reorganized

December 7, 1990

FDA Approves New Indication For Anticoagulant Frangmin

May 25, 2007